Literature DB >> 15766727

Characterization of high-affinity antibodies by electrochemiluminescence-based equilibrium titration.

Cornelia Haenel1, Marion Satzger, Daniela Della Ducata, Ralf Ostendorp, Bodo Brocks.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15766727     DOI： 10.1016/j.ab.2004.12.032

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  9 in total

1.  Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.

Authors:  Sonja Volk; Thomas D Schreiber; David Eisen; Calvin Wiese; Hannes Planatscher; Christopher J Pynn; Dieter Stoll; Markus F Templin; Thomas O Joos; Oliver Pötz
Journal:  Mol Cell Proteomics       Date:  2012-04-23       Impact factor: 5.911

2.  Affinity determination of biomolecules: a kinetic model for the analysis of pre-equilibrium titration curves.

Authors:  Emilie Vanhove; Marc Vanhove
Journal:  Eur Biophys J       Date:  2018-07-10       Impact factor: 1.733

3.  Crystallization and molecular-replacement solution of a diagnostic fluorescent dye in complex with a specific Fab fragment.

Authors:  Roman C Hillig; Siegfried Baesler; Stefanie Urlinger; Yvonne Stark; Susanne Bauer; Volker Badock; Martina Huber; Inke Bahr; Michael Schirner; Kai Licha
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-02-23

4.  An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.

Authors:  Estelle Lach-Trifilieff; Giulia C Minetti; KellyAnn Sheppard; Chikwendu Ibebunjo; Jerome N Feige; Steffen Hartmann; Sophie Brachat; Helene Rivet; Claudia Koelbing; Frederic Morvan; Shinji Hatakeyama; David J Glass
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

5.  Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth.

Authors:  Elena Gustchina; John M Louis; Christian Frisch; Francisco Ylera; Annette Lechner; Carole A Bewley; G Marius Clore
Journal:  Virology       Date:  2009-08-19       Impact factor: 3.616

6.  An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin.

Authors:  Andrew P Garner; Carl U Bialucha; Elizabeth R Sprague; Joan T Garrett; Qing Sheng; Sharon Li; Olga Sineshchekova; Parmita Saxena; Cammie R Sutton; Dongshu Chen; Yan Chen; Huiqin Wang; Jinsheng Liang; Rita Das; Rebecca Mosher; Jian Gu; Alan Huang; Nicole Haubst; Carolin Zehetmeier; Manuela Haberl; Winfried Elis; Christian Kunz; Analeah B Heidt; Kara Herlihy; Joshua Murtie; Alwin Schuller; Carlos L Arteaga; William R Sellers; Seth A Ettenberg
Journal:  Cancer Res       Date:  2013-08-08       Impact factor: 12.701

7.  High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Christian Frisch; Francisco Ylera; Stefan Harth; Achim Knappik; Amanda G Paulovich
Journal:  J Proteome Res       Date:  2014-03-06       Impact factor: 4.466

8.  Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensors.

Authors:  Michael E Brown; Daniel Bedinger; Asparouh Lilov; Palaniswami Rathanaswami; Maximiliano Vásquez; Stéphanie Durand; Ian Wallace-Moyer; Lihui Zhong; Juergen H Nett; Irina Burnina; Isabelle Caffry; Heather Lynaugh; Melanie Sinclair; Tingwan Sun; John Bukowski; Yingda Xu; Yasmina Noubia Abdiche
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

9.  High throughput solution-based measurement of antibody-antigen affinity and epitope binning.

Authors:  Patricia Estep; Felicia Reid; Claire Nauman; Yuqi Liu; Tingwan Sun; Joanne Sun; Yingda Xu
Journal:  MAbs       Date:  2013 Mar-Apr       Impact factor: 5.857
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.